Chiesi Pharmaceuticals

Parma, Italy Founded: 1935 • Age: 91 yrs
Developer of drugs for respiratory, neonatology, rare disease and special care therapeutic areas
Request Access

About Chiesi Pharmaceuticals

Chiesi Pharmaceuticals is a company based in Parma (Italy) founded in 1935.. Chiesi Pharmaceuticals has completed 5 acquisitions, including Amryt Pharma, Atopix Therapeutics and Cornerstone Therapeutics.

  • Headquarter Parma, Italy
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $437.48 K (USD), Grant

    Nov 23, 2023

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Chiesi Pharmaceuticals
Headcount 5000-10000
Employee Profiles 186
Board Members and Advisors 8
Employee Profiles
People
Mike Gordon
Group General Counsel, Executive Vice President- Group Legal & Compliance
People
Christine Hood
Head Of Global Learning
People
Marco Camin
Head of Global HRIS & HR Analytics
People
Lucia Santambrogio
Lead HR Business Partner, Global Franchises AIR & CARE

Unlock access to complete

Board Members and Advisors
people
Roch Doliveux
Board Member
people
Paolo Pucci
Board Member
people
Daphne Quimi
Board Member
people
Andrea Chiesi
Board Member

Unlock access to complete

Funding Insights of Chiesi Pharmaceuticals

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $437,476
  • First Round

    (01 Jul 2019)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2023 Amount Grant - Chiesi Pharmaceuticals Valuation

investors

Jan, 2020 Amount Grant - Chiesi Pharmaceuticals Valuation

investors

Jul, 2019 Amount Grant - Chiesi Pharmaceuticals Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Chiesi Pharmaceuticals

Chiesi Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Chiesi Pharmaceuticals

Chiesi Pharmaceuticals has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Amryt Pharma, Atopix Therapeutics and Cornerstone Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Therapeutics for rare dermatological and orphan diseases are developed.
2015
Medicines to treat atopic dermatitis and severe asthma
2012
Online platform for the purchase of dietary supplements
2008
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Chiesi Pharmaceuticals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Chiesi Pharmaceuticals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Chiesi Pharmaceuticals

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Chiesi Pharmaceuticals

Frequently Asked Questions about Chiesi Pharmaceuticals

When was Chiesi Pharmaceuticals founded?

Chiesi Pharmaceuticals was founded in 1935 and raised its 1st funding round 84 years after it was founded.

Where is Chiesi Pharmaceuticals located?

Chiesi Pharmaceuticals is headquartered in Parma, Italy. It is registered at Parma, Emilia-romagna, Italy.

Who is the current CEO of Chiesi Pharmaceuticals?

Giuseppe Accogli is the current CEO of Chiesi Pharmaceuticals.

What does Chiesi Pharmaceuticals do?

Founded in 1935 in Parma, Italy, Chiesi Pharmaceuticals operates in the pharmaceutical sector, with a focus on therapeutics for respiratory conditions, neonatology, rare diseases, and special care. Respiratory programs target asthma and chronic obstructive pulmonary disease through new chemical entities and reformulated anti-inflammatory and bronchodilator treatments. In neonatology, Curosurf is advanced for neonatal respiratory distress syndrome in late-stage trials.

How many acquisitions has Chiesi Pharmaceuticals made?

Chiesi Pharmaceuticals has made 5 acquisitions, including Amryt Pharma, Atopix Therapeutics, and Cornerstone Therapeutics.

Who are Chiesi Pharmaceuticals's investors?

Chiesi Pharmaceuticals has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available